The Serotonin Syndrome

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025

The serotonin syndrome

Sternbach, H. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.705 · Cited by 1,349

The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity

Dunkley, E. J. C., Isbister, G. K., Sibbritt, D. W., Dawson, A. H., & Whyte, I. M. (2003) · QJM · doi:10.1093/qjmed/hcg109 · Cited by 1,032

Neuroleptic malignant syndrome

Levenson, J. L. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1137 · Cited by 984

2002 annual report of the American association of poison control centers toxic exposure surveillance system

Watson, W. A., Litovitz, T. L., Rodgers, G. C., Klein‐Schwartz, W., Youniss, J., Rose, S. R., Borys, D. J., & May, M. E. (2003) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(03)00088-3 · Cited by 481

Interactions Between Herbal Medicines and Prescribed Drugs

Izzo, A., & Ernst, E. (2012) · Drugs · doi:10.2165/00003495-200161150-00002 · Cited by 464

Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose

Isbister, G. K., Bowe, S. J., Dawson, A. H., & Whyte, I. M. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120037428 · Cited by 432

The Libby Zion Case

Asch, D. A., & Parker, R. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181209 · Cited by 396

Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin Concentrations

Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. O. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 329

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 325

Neuroleptic Malignant Syndrome

Guzé, B. H., & Baxter, L. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507183130306 · Cited by 313

Serotonin Syndrome Presentation of 2 Cases and Review of the Literature

Mason, P. J., Morris, V. A., & Balcezak, T. J. (2000) · Medicine · doi:10.1097/00005792-200007000-00001 · Cited by 311

The serotonin syndrome and its treatment

Gillman, P. K. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300111 · Cited by 301

Treatment of the serotonin syndrome with cyproheptadine

Graudins, A., Stearman, A., & Chan, B. S. H. (1998) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(98)00057-2 · Cited by 300

Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor

Oates, J. A., & Sjoerdsma, A. (1960) · Neurology · doi:10.1212/wnl.10.12.1076 · Cited by 189

The serotonin syndrome scale: first results on validity

Hegerl, U., Ronald Bottlender, A., Gallinat, J., Kuss, H., Ackenheil, M., & Möller, H. (1998) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050024 · Cited by 180

Metabolic Acidosis in Restraint‐associated Cardiac ArrestA Case Series

Hick, J. L., Smith, S. W., & Lynch, M. T. (1999) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.1999.tb00164.x · Cited by 175

Antidepressants and the serotonin syndrome in general practice.

Mackay, F. J., Dunn, N. R., & Mann, R. D. (1999) · PubMed · Cited by 172

Potent serotonin (5-HT)2A receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome

Nisijima, K., Yoshino, T., Yui, K., & Katoh, S. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03020-1 · Cited by 161

Serotonin Syndrome

MARTIN, T. (1996) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(96)70116-6 · Cited by 142

Ayahuasca Preparations and Serotonin Reuptake Inhibitors: A Potential Combination for Severe Adverse Interactions

Callaway, J. C., & Grob, C. S. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399712 · Cited by 137

Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: Microdialysis studies in the awake and anaesthetized rat

Done, C., & Sharp, T. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90071-x · Cited by 128

Malignant hyperthermia

Ali, S. Z., Taguchi, A., & Rosenberg, H. R. (2003) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2003.09.012 · Cited by 118

Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine

DeSilva, K. E., Flore, D. B. L., Marston, B. J., & Rimland, D. (2001) · AIDS · doi:10.1097/00002030-200107060-00010 · Cited by 99

Ecstasy Intoxication: An Overlap Between Serotonin Syndrome and Neuroleptic Malignant Syndrome

Demirkıran, M., Jankovic, J. J., & Dean, J. M. (1996) · Clinical Neuropharmacology · doi:10.1097/00002826-199619020-00004 · Cited by 96

PET Evidence That Loxapine Is an Equipotent Blocker of 5-HT2and D2Receptors: Implications for the Therapeutics of Schizophrenia

Kapur, S., Zipursky, R. B., Remington, G. J., Jones, C., McKay, G., & Houle, S. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.11.1525 · Cited by 93

Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.

Ss, K., Ls, M., Scala-Barnett, D. M., & Zick, D. (1989) · PubMed · Cited by 78

Possible Serotonin Syndrome in Association With 5-HT3 Antagonist Agents

Turkel, S. B., Nadala, J. G. B., & Wincor, M. Z. (2001) · Psychosomatics · doi:10.1176/appi.psy.42.3.258 · Cited by 77

Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors

Mitchell, P. B. (1997) · Drug Safety · doi:10.2165/00002018-199717060-00005 · Cited by 76

Myoclonus and ocular oscillations induced by L ‐tryptophan

Baloh, R. W., Dietz, J., & Spooner, J. W. (1982) · Annals of Neurology · doi:10.1002/ana.410110117 · Cited by 68

Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome

Nisijima, K., Shioda, K., Yoshino, T., Takano, K., & Kato, S. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(02)00213-9 · Cited by 67

Toxic Serotonin Syndrome or Neuroleptic Malignant Syndrome?

Fink, M. (2007) · Pharmacopsychiatry · doi:10.1055/s-2007-979564 · Cited by 62

Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?

Isbister, G. K., Dawson, A. H., Whyte, I. M., Prior, F. H., CLANCY, C., & SMITH, A. J. (2001) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.85.2.f145g · Cited by 59

Serotonin Syndrome in a Child After a Single Dose of Fluvoxamine

Gill, M., LoVecchio, F., & Selden, B. S. (1999) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(99)70313-6 · Cited by 59

Cyproheptadine: a potent in vivo serotonin antagonist

Kapur, S., Zipursky, R. B., Jones, C. E., Wilson, A. A., DaSilva, J. N., & Houle, S. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.884a · Cited by 56

Sumatriptan Contraindications and the Serotonin Syndrome

Gardner, D. M., & Lynd, L. D. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17204 · Cited by 54

Serotonin Syndrome in a Child Associated with Erythromycin and Sertraline

Lee, D. O., & Lee, C. D. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.10.894.31561 · Cited by 48

Serotonin Syndrome as a Result of Fluoxetine in a Patient With Tramadol Abuse: Plasma Level-correlated Symptomatology

Lange‐Asschenfeldt, C., Weigmann, H., Hiemke, C., & Mann, K. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00022 · Cited by 48

Memantine, an NMDA Antagonist, Prevents the Development of Hyperthermia in an Animal Model for Serotonin Syndrome

Nisijima, K., Shioda, K., Yoshino, T., Takano, K., & Kato, S. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-815526 · Cited by 44

Functional study of rat 5‐HT2A receptors using antisense oligonucleotides

Oekelen, D. V., Megens, A. A. H. P., Meert, T. F., Luyten, W. H. M. L., & Leysen, J. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01738.x · Cited by 39

Serotonin syndrome: potentially fatal but difficult to recognize.

Sampson, E. L., & Warner, J. P. (1999) · PubMed · Cited by 32

Serotonin syndrome – ‘potential’ role of the CYP2D6 genetic polymorphism in Asians

Kaneda, Y., Kawamura, I., Fujii, A., & Ohmori, T. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002723 · Cited by 28

Increase in brain serotonin produced by bromocryptine

Snider, S. R., Hutt, C., Stein, B., & Fahn, S. (1975) · Neuroscience Letters · doi:10.1016/0304-3940(75)90067-1 · Cited by 28

SEROTONIN SYNDROME: POTENTIAL CONSEQUENCES OF MERIDIA COMBINED WITH DEMEROL OR FENTANYL

Giese, S. Y., & Neborsky, R. (2001) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200101000-00069 · Cited by 24

Ecstasy, serotonin syndrome and the treatment of hyperpyrexia

Gillman, P. K. (1997) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb138798.x · Cited by 23

Correspondence

Isbister, G. K., & Whyte, I. M. (2002) · British Journal of Anaesthesia · doi:10.1093/bja/88.4.603 · Cited by 22

The serotonin syndrome: investigation using the Japanese version of the Serotonin Syndrome Scale

Kaneda, Y., Ohmori, T., & Fujii, A. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00340-7 · Cited by 13

Comment: Serotonin Syndrome, Mydriasis, and Cyproheptadine

Isbister, G. K. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.16185b · Cited by 8

Comment: serotonin syndrome, mydriasis, and cyproheptadine

Isbister, G. K. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.10203a · Cited by 3

American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity

Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914

PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder

Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,372

Neurobiology of resilience

Russo, S. J., Murrough, J. W., Han, M.-H., Charney, D. S., & Nestler, E. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3234 · Cited by 1,206

Practice parameter for the assessment and treatment of children and adolescents with depressive disorders

Birmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056

Neonatal Drug Withdrawal

Hudak, M. L., Tan, R. C., Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Neville, K. A., Paul, I. M., van den Anker, J. N., Papile, L. A., Baley, J. E., et al. (2012) · PEDIATRICS · doi:10.1542/peds.2011-3212 · Cited by 889

Serotonin Syndrome

Ternaux, J.-P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374105-9.00421-4

Síndrome Serotoninérgico

Azofeifa, M. M., Chaves, J. C. V., Jiménez, S. V., & Díaz, F. A. (2019) · Americanae (AECID Library)

Serotonin syndrome in the perioperative period

Bartakke, A., Corredor, C., & van Rensburg, A. (2019) · BJA Education · doi:10.1016/j.bjae.2019.10.003 · Cited by 21

Serotonin Syndrome Following Single Ingestion of High Dose Methamphetamine

Rahmani, S. H. (2011) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.1000111 · Cited by 5

Practice pointer: serotonin syndrome

Buckley, N. A., Dawson, A. H., & Isbister, G. K. (2014) · NOVA (University of Newcastle Australia)